Techniques: Synthetic biology-based protocol to differentiate human induced pluripotent stem (iPS) cell-derived pancreatic progenitors into mature β-like cells

A synthetic lineage-control network could program human iPS cell-derived pancreatic progenitor cells into mature β-like cells used to treat diabetes. In human iPS cell-derived pancreatic progenitors, ...